• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.64 Up 0.02(3.25%) Jan 30, 4:01PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 152   123   288   510  
    Cost of Revenue41  18  130  80  
    Gross Profit 111   105   158   430  
    Operating Expenses
    Research Development2,312  2,238  2,528  4,037  
    Selling General and Administrative1,912  1,653  1,708  1,259  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,113) (3,786) (4,078) (4,866)
    Income from Continuing Operations
    Total Other Income/Expenses Net(106)854  513  720  
    Earnings Before Interest And Taxes(4,219)(2,932)(3,565)(4,146)
    Interest Expense -   -   -   -  
    Income Before Tax(4,219)(2,932)(3,565)(4,146)
    Income Tax Expense -  10   -  (9)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,219)(2,942)(3,565)(4,137)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,219) (2,942) (3,565) (4,137)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (4,219) (2,942) (3,565) (4,137)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.